Dr. Ali Yalcindag, MD
- Part D claims, 2024
- 37
- Publications
- 13
- Clinical trials
- 1
- Affiliated sites
- 2
- Medical group
- 1
- Practice address
- 593 Eddy St, Providence, RI 02903
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Rhode Island Hospital - HOPD
Acute Care Hospital outpatient department · Providence, Rhode Island
Find Dr. Yalcindag's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ali Yalcindag is a pediatric rheumatology physician in Providence, Rhode Island
Dr. Yalcindag practices at Rhode Island Hospital - HOPD in Providence, Rhode Island.
Dr. Yalcindag's NPI, 1750337796, was assigned on May 25, 2006. Dr. Yalcindag graduated from Istanbul University Fom in 1994. Dr. Yalcindag holds Rhode Island license MD11082.
- NPI
- 1750337796NPI Registry (opens in a new tab)
- NPI enumeration date
- May 25, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1994
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Ali Yalcindag practices at Rhode Island Hospital - HOPD in Providence, Rhode Island
Dr. Yalcindag's primary practice is Rhode Island Hospital - HOPD, at 593 Eddy St, Providence, RI 02903.
- Rhode Island Hospital - HOPD593 Eddy St, Providence, RI 02903
Source: Dmand AI Affiliation Data
Dr. Ali Yalcindag is affiliated with 2 sites of care and 1 medical group
Dr. Yalcindag's primary practice is Rhode Island Hospital - HOPD in Providence, Rhode Island. The medical group on file is Rhode Island Hospital. Dmand AI also links Dr. Yalcindag to 1 more group practice or clinic, named with a free account. Dr. Yalcindag's employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Ali Yalcindag's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yalcindag practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Rhode Island Hospital - HOPD | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ali Yalcindag is one of 2 pediatric rheumatology physicians in Rhode Island
Pediatric rheumatology is Dr. Yalcindag's primary specialty in the NPI Registry, under taxonomy code 2080P0216X. Dr. Yalcindag is board certified in pediatric rheumatology by the American Board of Pediatrics. Dmand AI has Dr. Yalcindag's licenses on file in 3 states: Rhode Island, Massachusetts and Connecticut.
Specialties and state licenses
- Pediatric rheumatology, Rhode IslandPrimary
- Massachusetts license
- Connecticut license
Pediatric rheumatology physicians near Dr. Yalcindag
Counts of pediatric rheumatology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ali Yalcindag's patients have a median age of 16
Across all payers, Dmand AI patient panel data puts Dr. Yalcindag's median patient age at 16, with 71% women.
Dr. Yalcindag's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 16
Patient panel by sex, all payers
- Women71%
- Men28%
Source: Dmand AI Patient Panel Data
Dr. Ali Yalcindag wrote 37 Medicare Part D claims in 2024
In 2024, Dr. Yalcindag wrote 37 Medicare Part D claims. 41% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $181,679 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.
Dr. Yalcindag's Part D claims by kind of drug, 2024
- Generic15 claims41%
- Brand-name22 claims59%
Dr. Yalcindag's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 252024: 25No change
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ali Yalcindag has 13 publications on record
Dmand AI links 13 papers to Dr. Yalcindag, published from 2006 to 2024. 2022 was the busiest year, with 3. The most frequent topics are COVID-19, Disease Models, Animal and Mice, Knockout. Dr. Yalcindag has published most often in Pediatrics. Dr. Yalcindag's most frequent co-authors are Maria Chauncy Bryant, MD, Matthew David Adams, MD and Stacy Payne Ardoin, MD.
Dr. Yalcindag's papers by year, 2006 to 2024
Topics Dr. Yalcindag writes about most
- COVID-19
- Disease Models, Animal
- Mice, Knockout
- Ovalbumin
- SARS-CoV-2
- Th2 Cells
Dr. Yalcindag's most frequent co-authors
- Maria Chauncy Bryant, MD2 shared papers
- Matthew David Adams, MD1 shared paper
- Stacy Payne Ardoin, MD1 shared paper
Recent publications by Dr. Yalcindag
R I Med J (2013)
Pediatr Rheumatol Online J
R I Med J (2013)
See who Dr. Yalcindag researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yalcindag works with, so you can find a warm path to the right pediatric rheumatology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ali Yalcindag has worked on 1 clinical trial
Dmand AI links Dr. Yalcindag to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Negative rheumatoid factor polyarthritis and Arthritis, Juvenile.
Conditions in Dr. Yalcindag's trials
- Negative rheumatoid factor polyarthritis
- Arthritis, Juvenile
Investigators on the most trials with Dr. Yalcindag
- Khalid Mohammed Abulaban, MD1 shared trial
- Cassyanne L. Aguiar Lapsia, MD1 shared trial
- Eric Jon Allenspach, MD, PhD1 shared trial
Recent clinical trials with Dr. Yalcindag
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Ali Yalcindag has 1 award and honors on record
Dmand AI lists 1 award for Dr. Yalcindag.
Awards and honors for Dr. Yalcindag
- Undated
- ACR Fellow
Source: Dmand AI Professional Profile Data
Dr. Ali Yalcindag graduated from Istanbul University Fom
Dr. Yalcindag graduated from Istanbul University Fom in 1994.
- Medical school
- Board certified in pediatric rheumatology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Ali Yalcindag accepts plans from 12 insurance carriers
Dr. Yalcindag is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Elevance
- Aspirus Health Plan
- HCSC
- Alliant Health Plans
- Blue Cross and Blue Shield of Kansas City
- +4 more carriersWith a free account
Plan types Dr. Yalcindag accepts, by number of carriers
- HMO7
- PPO6
- EPO4
- POS4
- Medicaid2
- Medicare2
Source: Dmand AI Insurance Network Data
Sources for Dr. Ali Yalcindag's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ali Yalcindag
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ali Yalcindag's NPI number?
Dr. Ali Yalcindag's NPI number is 1750337796. It was assigned on May 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Ali Yalcindag?
Dr. Ali Yalcindag is a pediatric rheumatology physician in Providence, Rhode Island. The primary specialty in the NPI Registry is Pediatric Rheumatology Physician (taxonomy code 2080P0216X).
Where does Dr. Ali Yalcindag practice?
Dr. Yalcindag practices at 593 Eddy St, Providence, RI 02903. Dr. Yalcindag's primary practice is Rhode Island Hospital - HOPD in Providence, Rhode Island. Dmand AI also links Dr. Yalcindag to 1 group practice or clinic.
What is Dr. Ali Yalcindag's medical license number?
Dr. Yalcindag holds Rhode Island license MD11082, one of the licenses on file in 3 states.
Which states has Dr. Ali Yalcindag been licensed in?
Dmand AI has state licenses on file for Dr. Yalcindag in Rhode Island (2003 to 2026), Massachusetts (1999 to 2026) and Connecticut (2002 to 2016).
What medical group is Dr. Ali Yalcindag part of?
Dr. Yalcindag is linked to Rhode Island Hospital.
Is Dr. Ali Yalcindag board certified?
Yes. Dr. Yalcindag is board certified in pediatric rheumatology by the American Board of Pediatrics.
Where did Dr. Ali Yalcindag go to medical school?
Dr. Yalcindag graduated from Istanbul University Fom in 1994.
What drugs does Dr. Ali Yalcindag prescribe most?
In 2024 Medicare Part D data, Dr. Yalcindag's most prescribed drugs by claims were Humira(Cf) Pen and Mycophenolate Mofetil.
How long has Dr. Ali Yalcindag been practicing?
Dr. Yalcindag graduated from medical school in 1994, 32 years ago.
Show 3 more questionsShow fewer questions
Does Dr. Ali Yalcindag do research?
Dmand AI links 13 publications to Dr. Yalcindag, published from 2006 to 2024. Dr. Yalcindag has worked on 1 clinical trial.
Who does Dr. Ali Yalcindag publish with?
Dr. Yalcindag's most frequent co-authors are Maria Chauncy Bryant, MD (2 shared papers), Matthew David Adams, MD (1 shared paper) and Stacy Payne Ardoin, MD (1 shared paper).
What insurance does Dr. Ali Yalcindag accept?
Dr. Yalcindag is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to pediatric rheumatology practices?
See pediatric rheumatology physicians in Rhode Island by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card